23 Result(s)

Article

“Orthogonal polarization spectral imaging”Eine neue klinische Methode für das Monitoring der Mikrozirkulation

Mit “orthogonal polarization spectral imaging” (OPS-Imaging) steht ein neues nichtinvasives Untersuchungsverfahren zur Verfügung, das mikrovaskuläre Veränderungen am Menschen für verschiedene Organe direkt sic...

C. Schießler, S. Schaudig, A. G. Harris, F. Christ in Der Anaesthesist (2002)

Chapter and Conference Paper

Quantitative Analyse der Mikrozirkulation von Wunden mit OPS imaging

Introduction: Orthogonal polarization spectral (OPS) imaging, implemented into the CYTOSCAN A/R, is a new, recently introduced technique to produce high contrast images of the microcirculation wi...

Dr. med. Stefab Langer, F. Born, R. Hatz… in Chirurgisches Forum 2001 für experimentell… (2001)

Chapter and Conference Paper

The Study of the Microcirculation using Orthogonal Polarization Spectral Imaging

The microcirculation is an extremely important part of the body where blood interacts with tissue to create an environment necessary for cell survival [1]. As such, an understanding of its function under both ...

A. G. Harris, S. Langer, K. Messmer in Yearbook of Intensive Care and Emergency M… (2000)

Chapter and Conference Paper

Validierung des „OPS imaging“ Verfahrens an der Rattenleber

Hintergrund: Störungen der hepatischen Mikrozirkulation sind wesentlich an der Pathophysiologie der postischämischen Organdysfunktion nach Leberchirurgie sowie Trans-plantation beteiligt. Die qua...

Dr. med. S. Langer, A. G. Harris… in Chirurgisches Forum 2000 für experimentell… (2000)

Article

Implementation of the Microdialysis Method in the Hamster Dorsal Skinfold Chamber

The aim of this study was to implement the microdialysis method, a well-established technique for measuring the local concentration of neurotransmitters and metabolites in the brain, in the dorsal skinfold cha...

A. G. Harris, A. Schropp, E. Schütze, F. Krombach… in Research in Experimental Medicine (1999)

Chapter and Conference Paper

Langzeitkonservierung mit UW versus EC verbessert die Revaskularisierung des transplantierten Knochens

Zur Überbrückung langstreckiger Röhrenknochendefekte und zur Wiederherstellung der Gelenkfunktion nach Trauma wurde durch die allogene Transplantation vaskularisierter Knochen und Gelenke eine neue Behandlungs...

Dr. med. Martin H. Kirschner, L. Suess… in Chirurgisches Forum ’99 für experimentelle… (1999)

Article

Solitary Hepatic Infantile Myofibromatosis in a Female Adolescent

P. Hastier, F. X. Caroli-Bosc, A. G. Harris… in Digestive Diseases and Sciences (1998)

Chapter and Conference Paper

Oxaceprol reduziert die Leukozyten-Adhärenz und -Extravasation und erhält die Perfusion des Gewebes nach Ischämie/Reperfusion (I/R) aufrecht

Akkumulation von Leukozyten, Beeinträchtigung der Perfusion sowie Steigerung der Permeabilität kennzeichnen den mikrovaskulären Ischämie/Reperfusions (I/R)-Schaden. Das Antiphlogistikum Oxaceprol ist zugelasse...

A. G. Harris, A. Schropp, K. Meßmer in Chirurgisches Forum ’98 (1998)

Article

Pyoderma gangrenosum with hepatopancreatic manifestations in a patient with rheumatoid arthritis

Pyoderma gangrenosum is a dermatological disease of unknown origin. We report the case of a 47-year-old woman with cutaneous lesions of pyoderma gangrenosum associated with hepaticopancreatic involvement. We f...

P. Hastier, F. X. Caroli-Bosc, H. R. Bartel… in Digestive Diseases and Sciences (1996)

Article

Consensus statement: Octreotide dose titration in secretory diarrhea

Octreotide is an effective therapeutic option in controlling secretory diarrhea of varied etiology. However, marked patient-to-patient differences in the antidiarrheal effects necessitate titration of octreoti...

A. G. Harris, Dr. T. M. O'Dorisio, E. A. Woltering… in Digestive Diseases and Sciences (1995)

Article

A prospective multicenter octreotide dose response study in the treatment of acromegaly

The somatostatin analog octreotide has proven to be an effective form of treatment for various hypersecretory states including acromegaly. This report describes the effects of escalating doses of octreotide on...

Shereen Ezzat M.D., D. A. Redelmeier, M. Gnehm… in Journal of Endocrinological Investigation (1995)

Article

Effects of octreotide on biliary lipid composition and occurrence of cholesterol crystals in patients with acromegaly

Treatment with the somatostatin analog octreotide is associated with increased gallstone formation. The mechanism of formation of these stones is unclear. The purpose of this study was to examine the effect of...

Dr. S. Erlinger, P. Chanson, M. Dumont, P. Ponsot… in Digestive Diseases and Sciences (1994)

Article

Clinical use of the long acting somatostatin analogue octreotide in pediatrics

Preliminary data of the use of the long-acting somatostatin analog octreotide (Sandostatin) in pediatrics are reported. In nesidioblastosis and other hyperinsulinemic conditions, timely treatment with octreoti...

M. T. Tauber, A. G. Harris, P. Rochiccioli in European Journal of Pediatrics (1994)

Chapter and Conference Paper

Receptors and Their Modulation

The potential for hormonal intervention in cancer was identified as early as 1895, even before the concept of hormones was established. Indeed, we know that the first hormone was discovered only in 1902 (secre...

F. X. Caroli-Bosc, P. Hastier, A. G. Harris, P. Gaudray… in Facing the Pancreatic Dilemma (1994)

Article

Reduction in sella turcica volume

Ten patients with acromegaly were treated with the long-acting somatostatin analogue, Sandostatin (SMS 201-995, octreotide) for more than one year. Computerized tomography was performed before and on 4 differe...

E. Lund, J. Jørgensen, S. E. Christensen, J. Weeke, H. Ørskov… in Neuroradiology (1991)

Chapter and Conference Paper

Heart Size Reduction in Acromegalic Patientes Treated with the Long-Acting Somatostatin-Analogue SMS 201–995 (Somatostatin®)

Cardiomegaly by hypertrophy of the heart in acromegalic patients — prevalence 85% in our patients with acromegaly [1] — is often complicated by complex arrhythmias and gradual cardiac-insufficiency [1, 3, 8]. ...

P.-H. Althoff, K. Schmidt, D. Rübesam, A. G. Harris… in Endocrinology of the Heart (1989)

Chapter and Conference Paper

Effects of Long-Term Administration of Sandostatin^® (SMS 201–995) at Increasing Doses in 40 Acromegalic Patients. Results from the French Sandostatin Acromegaly Study Group

Several studies demonstrate the efficacy of short- and long-term Sandostatin^® treatment in acromegaly administered subcutaneously at doses ranging from 150 to 300 µg up to 600 µg per day [1, 3, 5, 7–10]. A rhythm...

G. Sassolas, P. Fossati, P. Chanson… in Sandostatin® in the Treatment of Acromegaly (1988)

Chapter and Conference Paper

Observations During a Clinical Trial of Sandostatin^® in Acromegalic Patients

Ten acromegalic patients were studied over a period of 75 weeks. Four had had one or more attempted ablations of their pituitary adenoma, six were previously untreated or had been unsuccessfully treated with b...

H. Ørskov, J. Weeke, S. E. Christensen… in Sandostatin® in the Treatment of Acromegaly (1988)